Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity. - Wikidata - awgldk - TriplyDB

Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity.

Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity.

http://www.wikidata.org/entity/Q34326400

about

Focus on adoptive T cell transfer trials in melanoma Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia Suicide gene therapy to increase the safety of chimeric antigen receptor-redirected T lymphocytes Adoptive cell transfer: a clinical path to effective cancer immunotherapy T cell avidity and tumor recognition: implications and therapeutic strategies.Harnessing the immune system to improve cancer therapy Cancer immunotherapy: the beginning of the end of cancer?Different Subsets of T Cells, Memory, Effector Functions, and CAR-T Immunotherapy Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and Prospects Adoptive T-cell therapies for refractory/relapsed leukemia and lymphoma: current strategies and recent advances Novel immunotherapies in lymphoid malignancies Beyond CD19: Opportunities for Future Development of Targeted Immunotherapy in Pediatric Relapsed-Refractory Acute Leukemia CD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL)Adoptive immunotherapy for acute leukemia: New insights in chimeric antigen receptors Strategies for combining immunotherapy with radiation for anticancer therapy CAR T Cell Therapy: A Game Changer in Cancer Treatment B7-H4 as a potential target for immunotherapy for gynecologic cancers: a closer look A new approach to gene therapy using Sleeping Beauty to genetically modify clinical-grade T cells to target CD19 Genetically modified T cells for the treatment of malignant disease Synthetic biology in mammalian cells: next generation research tools and therapeutics Immunotherapy for primary brain tumors: no longer a matter of privilege Novel immunotherapies for hematologic malignancies Adoptive T-cell therapy for Leukemia Catch me if you can: Leukemia Escape after CD19-Directed T Cell Immunotherapies Immunological and Translational Aspects of NK Cell-Based Antitumor Immunotherapies Summary of emerging targets in anal cancer: the case for an immunotherapy based-approach CD19-Chimeric Antigen Receptor T Cells for Treatment of Chronic Lymphocytic Leukaemia and Acute Lymphoblastic Leukaemia T cell engineering as therapy for cancer and HIV: our synthetic future Utilizing chimeric antigen receptors to direct natural killer cell activity Are BiTEs the "missing link" in cancer therapy?CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia Adapting antibodies for clinical use.Engineering of monoclonal antibodies and antibody-based fusion proteins: successes and challenges.Selection of human antibody fragments directed against tumor T-cell epitopes for adoptive T-cell therapy.Lymphocyte display: a novel antibody selection platform based on T cell activation FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance Strategies to genetically engineer T cells for cancer immunotherapy.Immunotherapy for solid tumors--a review for surgeons.Genome-Edited T Cell Therapies.

P2860

Q21328679-8D1483CF-9FCC-4BD0-B9D3-C8ABD147A9F9 Q24594920-EAD11C66-CA60-47BE-9A55-8CE02FB8594C Q24632975-63482672-FF18-45CE-9422-9EC917064700 Q24633960-509CBE23-3881-42AD-8B31-C53351F20844 Q24644774-4D534ED9-93BC-4A8E-9413-918CA2ACD27A Q24815775-355919D6-39EB-4D24-B0B4-9917F4820EE5 Q26738698-54681434-1C0D-4DC5-912E-0F4D5175ED1B Q26752277-1D7BDF50-7022-4C30-96B1-43EDEDE0CBCF Q26752955-589B749E-E620-41EF-8BB6-85F404802F30 Q26753082-673F4A6E-52FF-4429-A7D2-0884F9BE2721 Q26775720-57C2F333-4869-4F52-A1D5-7386728746AD Q26777394-35755FD0-185C-48ED-9A9C-515049D03794 Q26781328-A0481B48-DBE4-446F-84E2-81999C11CEAB Q26783433-74280829-E655-448D-A537-A567C0896329 Q26795540-E1AC81A5-C19D-4383-8875-DB42F4BAA89F Q26796675-9F5890A6-FADA-420F-B63F-96E0C6DE1AE2 Q26822769-4FBA01FB-D679-4CC8-A401-B1737296A898 Q26824446-CE091F1E-6762-4F96-BB5D-C7BA19341C39 Q26849476-1B0C4044-738D-4C68-96AC-79F2EB9F4BAB Q26860657-D1C8C08E-6D37-4300-9710-400B177F04B2 Q26995293-BEA02E69-AAEC-4E04-99BD-8C9C2AEA7391 Q27002510-F115751D-2A9D-4F74-9920-2A1195AAFD96 Q27004436-C63A5B34-3B92-49FE-AEA8-F3DAB10C5A19 Q27006934-D92014F6-3276-4202-BEB8-C821730D14D6 Q28072131-2B05B706-8640-4643-A43D-F60984398A29 Q28079180-59BEF233-20CC-4F98-B6A2-2A45282B2A7B Q28080081-20F1B570-9BF8-4F3B-8895-0BDDF99F22FB Q28081600-09ED512F-1E8E-4708-A231-B2EF81328ED8 Q28082253-4DEC3648-3D36-4845-AC15-938AD36C91B2 Q28082868-ECAD9735-B1EA-4922-82E6-1500B7CA7C22 Q28083907-6D38311A-B8AE-49ED-9DF7-E4C2C6456F6A Q28084879-8C4E0323-7359-4E5A-8F40-6A1C0C4DCBC8 Q33197771-2E1F7CA2-3DB2-46C5-970D-8835A41E5332 Q33224048-54FCE36A-4DD1-4DD9-8AA9-03071CEB498A Q33368725-579CAFFD-3F56-44E7-9E90-A42734524BDF Q33506415-B18DFAA7-7D4C-4E25-A268-8A4E62BF5588 Q33607015-52C23524-5CBA-4E15-A65E-D7C0F0D28AC3 Q33655849-19B8FCCB-1E82-40BE-9E1E-7C39065E2FEE Q33709232-34A79E66-273E-40B0-B052-2E3FDF229DEE Q33729598-974B3AD6-8D8C-438B-8C58-5A3C133CC2AC

P2860

Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity.

http://www.wikidata.org/entity/Q34326400

description

1989 nî lūn-bûn

@nan

1989 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1989 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1989年の論文

@ja

1989年論文

@yue

1989年論文

@zh-hant

1989年論文

@zh-hk

1989年論文

@zh-mo

1989年論文

@zh-tw

1989年论文

@wuu

name

Expression of immunoglobulin-T ...... ith antibody-type specificity.

@ast

Expression of immunoglobulin-T ...... ith antibody-type specificity.

@en

Expression of immunoglobulin-T ...... ith antibody-type specificity.

@nl

type

label

Expression of immunoglobulin-T ...... ith antibody-type specificity.

@ast

Expression of immunoglobulin-T ...... ith antibody-type specificity.

@en

Expression of immunoglobulin-T ...... ith antibody-type specificity.

@nl

prefLabel

Expression of immunoglobulin-T ...... ith antibody-type specificity.

@ast

Expression of immunoglobulin-T ...... ith antibody-type specificity.

@en

Expression of immunoglobulin-T ...... ith antibody-type specificity.

@nl

P1433

Q34326400-57771645-6056-4ED5-940D-D744D55619B8

P1476

Q34326400-5EF0FCCF-C38F-48CA-8782-407B23091A9A

P2093

Q34326400-162E28B6-63A1-4D98-85C4-35B89934A574

Q34326400-BC12B558-4F55-4947-933E-C5DAF07EFBE2

Q34326400-C0AA5214-E7E3-40BD-BEC1-4BA8B389A238

P2860

Q34326400-049C05E6-1F0D-4681-80EE-7D2D92EC7F16

Q34326400-17030036-52B1-4552-AB3F-D2D51A78BB3F

Q34326400-1B381839-CED4-4846-9E09-F6143FC7CDD7

Q34326400-2BF8078D-49FE-44BC-97F4-A55DFE7F1B4C

Q34326400-30D2AAC1-2797-4671-B4AA-DFFCE7F2F966

Q34326400-423201ED-CB34-4C16-B0B6-51BFA08E99B4

Q34326400-4388278F-C026-44AB-9CFA-E6326A80792B

Q34326400-46100526-E5F8-4C58-8CCC-366EE9D9967F

Q34326400-5798CF57-A9B3-4370-8636-F082E973558B

Q34326400-60864086-AF21-4431-9A4A-70770031AF86

P304

Q34326400-1E401335-15C9-4236-ABA3-69D209EEEE82

P31

Q34326400-80D14423-6CF7-49CD-A830-B92560D6AA9F

P356

Q34326400-4E006C58-82BF-49A4-867B-609DB70CED23

P407

Q34326400-41461884-D8A9-4A20-8B9A-259B7020E500

P433

Q34326400-2EEF83A0-6E31-4BBB-904C-638F0C137052

P478

Q34326400-8A400EA4-5E72-4403-A4E0-9F7E124852A6

P577

Q34326400-FEC93702-7EA8-4FD3-B972-BAA8D2E9C0A3

P5875

Q34326400-52A5C057-3D99-42A9-B1E0-94AFDB913217

P698

Q34326400-03438CA5-6FAD-4A21-B7D6-BB20C1F318F9

P921

Q34326400-8357E86A-B6F0-4C6E-9E4B-9969DC2CF01A

P932

Q34326400-5CFBEBA1-8460-444E-933A-A3CFDB709771

P356

PNAS.86.24.10024

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Expression of immunoglobulin-T ...... ith antibody-type specificity.

@en

P2093

Eshhar Z

http://www.w3.org/2001/XMLSchema#string

Gross G

http://www.w3.org/2001/XMLSchema#string

Waks T

http://www.w3.org/2001/XMLSchema#string

P2860

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter

Structure of the human antibody molecule Kol (immunoglobulin G1): an electron density map at 5 A resolution.

T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex.

Secretion of a chimeric T-cell receptor-immunoglobulin protein.

Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase.

Cytotoxic T lymphocyte hybridomas that mediate specific tumor-cell lysis in vitro.

Mutant immunoglobulin genes have repetitive DNA elements inserted into their intervening sequences.

P304

10024-10028

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.86.24.10024

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P577

1989-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20641711

http://www.w3.org/2001/XMLSchema#string

P698

2513569

http://www.w3.org/2001/XMLSchema#string

P921

P932

298636

http://www.w3.org/2001/XMLSchema#string